October 21, 2011
The U.S. Food & Drug Administration (FDA) has accepted Sanofi’s new drug application (NDA) for oral teriflunomide as a potential therapy for people with relapsing forms of multiple sclerosis
- /
- /
Sanofi and its subsidiary, Genzyme, announced Thursday, October 20, that the U.S. Food & Drug Administration (FDA) has accepted Sanofi’s…